Huons starts to export KRW 89 billion ‘lidocaine injections’ to the U.S.
Huons(CEO Ki-Ahn Eum), a subsidiary of Huons Global, will actively start to target the U.S. market for 1% Lidocaine 5mL Ample, an injection-type finished drug which acquired the new drug application(ANDA) from the U.S. FDA on the last 4th.
Huons announced on the 8th that the company signed a lon...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
